Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.190
0.00 (0.00%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Ovid Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.57 | 0.39 | 1.5 | 208.38 | 12.62 | - | Upgrade
|
| Revenue Growth (YoY) | 186.16% | -73.93% | -99.28% | 1551.57% | - | - | Upgrade
|
| Gross Profit | 0.57 | 0.39 | 1.5 | 208.38 | 12.62 | - | Upgrade
|
| Selling, General & Admin | 27.96 | 31.09 | 32.43 | 37.23 | 30.63 | 19.25 | Upgrade
|
| Research & Development | 38.96 | 28.59 | 24.62 | 46.94 | 63.42 | 42.16 | Upgrade
|
| Operating Expenses | 66.92 | 59.67 | 57.05 | 84.17 | 94.05 | 61.41 | Upgrade
|
| Operating Income | -66.35 | -59.28 | -55.55 | 124.21 | -81.43 | -61.41 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.4 | 0.95 | Upgrade
|
| Other Non Operating Income (Expenses) | 33.82 | 4.94 | 1.83 | -0.05 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -32.53 | -54.34 | -53.71 | 124.16 | -81.04 | -60.46 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.58 | 2 | -0.45 | - | - | - | Upgrade
|
| Pretax Income | -29.75 | -52.34 | -54.17 | 124.16 | -81.04 | -60.46 | Upgrade
|
| Income Tax Expense | - | - | - | 1.33 | - | - | Upgrade
|
| Net Income | -29.75 | -52.34 | -54.17 | 122.83 | -81.04 | -60.46 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | 3 | - | - | Upgrade
|
| Net Income to Common | -29.75 | -52.34 | -54.17 | 119.84 | -81.04 | -60.46 | Upgrade
|
| Shares Outstanding (Basic) | 71 | 71 | 70 | 67 | 58 | 39 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 71 | 70 | 68 | 58 | 39 | Upgrade
|
| Shares Change (YoY) | 0.35% | 0.22% | 3.46% | 16.45% | 49.04% | 59.22% | Upgrade
|
| EPS (Basic) | -0.42 | -0.74 | -0.77 | 1.78 | -1.39 | -1.54 | Upgrade
|
| EPS (Diluted) | -0.42 | -0.74 | -0.77 | 1.76 | -1.39 | -1.54 | Upgrade
|
| Free Cash Flow | -52.98 | -45.82 | -56.45 | 118.43 | -51.71 | -51.15 | Upgrade
|
| Free Cash Flow Per Share | -0.75 | -0.65 | -0.80 | 1.74 | -0.88 | -1.30 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | Upgrade
|
| Operating Margin | -11687.87% | -15134.60% | -3696.44% | 59.61% | -645.40% | - | Upgrade
|
| Profit Margin | -5240.13% | -13362.17% | -3604.66% | 57.51% | -642.26% | - | Upgrade
|
| Free Cash Flow Margin | -9331.81% | -11698.19% | -3756.55% | 56.83% | -409.85% | - | Upgrade
|
| EBITDA | -65.78 | -58.71 | -55.04 | 124.45 | -81.12 | -61.15 | Upgrade
|
| EBITDA Margin | - | - | - | 59.72% | - | - | Upgrade
|
| D&A For EBITDA | 0.57 | 0.57 | 0.51 | 0.24 | 0.31 | 0.26 | Upgrade
|
| EBIT | -66.35 | -59.28 | -55.55 | 124.21 | -81.43 | -61.41 | Upgrade
|
| EBIT Margin | - | - | - | 59.61% | - | - | Upgrade
|
| Effective Tax Rate | - | - | - | 1.07% | - | - | Upgrade
|
| Revenue as Reported | 0.57 | 0.39 | 1.5 | 208.38 | 12.62 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.